```html

Keratitis Sicca (Corneal Dryness) – A Complete Guide

What is Keratitis Sicca (Corneal Dryness)?

Keratitis sicca, commonly called dry eye disease affecting the cornea, is a condition in which the surface of the eye—particularly the cornea—fails to stay adequately lubricated. The cornea is the clear, dome‑shaped front layer of the eye that refracts light. When it becomes dry, the protective tear film breaks down, leading to irritation, inflammation, and, if untreated, damage to the epithelial cells that line the cornea.

The term comes from the Greek keratitis (inflammation of the cornea) and the Latin sicca (dry). Although “keratitis” suggests inflammation, most cases of keratitis sicca are primarily a problem of tear deficiency rather than an infectious process.

Dry eye disease is very common—affecting an estimated 5–30 % of adults worldwide, with prevalence rising with age and in women, especially after menopause. When the dryness is severe enough to involve the cornea, patients may describe the sensation as “gritty,” “burning,” or “foreign‑body” feeling.

Common Causes

Dryness of the cornea can be triggered by a variety of systemic, ocular, environmental, and medication‑related factors. Below are the most frequent contributors (each may act alone or in combination):

• Age‑related tear‑film decline – Tear production naturally wanes after age 40.
• Hormonal changes – Menopause, pregnancy, and oral contraceptives alter the composition of tears.
• Autoimmune disorders – Sjögren’s syndrome, rheumatoid arthritis, lupus, and graft‑vs‑host disease often reduce tear secretion.
• Meibomian gland dysfunction (MGD) – Blocked or altered oil glands lead to rapid evaporation of the tear film.
• Medications – Antihistamines, decongestants, antidepressants, beta‑blockers, isotretinoin, and some chemotherapy agents have anticholinergic effects that lower tear output.
• Contact lens wear – Long‑term wear can disrupt the ocular surface and increase evaporation.
• Environmental exposures – Low humidity, wind, air conditioning, and smoke accelerate tear evaporation.
• Surgical procedures – LASIK, cataract extraction, and ptosis surgery may temporarily impair corneal innervation, reducing reflex tearing.
• Blepharitis – Inflammation of the eyelid margin interferes with lipid layer secretion.
• Neurologic diseases – Facial nerve palsy or trigeminal neuropathy can diminish sensory feedback needed for tear production.

Identifying the underlying cause is essential because treatment is most successful when it targets the root problem.

Associated Symptoms

Patients with keratitis sicca frequently notice a cluster of symptoms that arise from both tear deficiency and secondary surface inflammation:

• Burning, stinging, or itching sensation.
• Sensation of a foreign body or grit in the eye.
• Redness (especially around the cornea).
• Blurred vision that improves with blinking.
• Sensitivity to light (photophobia).
• Excessive tearing (reflex tearing) that paradoxically follows dryness.
• Difficulty wearing contact lenses.
• Sticky or stringy discharge, especially upon waking.
• Eye fatigue, especially after prolonged screen use.

When to See a Doctor

While occasional eye irritation is common, the following situations warrant a prompt ophthalmology consultation:

• Symptoms persist for more than a week despite over‑the‑counter lubricants.
• Repeated episodes of blurred vision that do not clear quickly with blinking.
• Persistent redness or pain that worsens, especially if accompanied by a feeling of pressure.
• White or yellowish spots on the cornea, which may indicate ulceration.
• Sudden increase in photophobia or light sensitivity.
• Any history of autoimmune disease, recent eye surgery, or use of systemic medications known to affect tear production.
• Persistent discharge, especially if thick, green, or yellow, suggesting a superimposed infection.

Early evaluation helps prevent chronic corneal damage and potential vision loss.

Diagnosis

Diagnosis begins with a thorough history and eye‑exam, followed by specific tests to quantify tear production and assess ocular surface health.

Clinical History

• Onset, duration, and pattern of symptoms.
• Medication list, systemic illnesses, and previous ocular surgeries.
• Environmental factors (workplace, screen time, climate).
• Lifestyle habits such as smoking, contact lens wear, and use of cosmetics.

Slit‑Lamp Examination

The ophthalmologist uses a bright microscope with a high‑intensity light to inspect the cornea, conjunctiva, and eyelid margins. Key findings may include:

• Distorted tear‑film meniscus (reduced tear volume).
• Staining of the corneal epithelium with fluorescein or rose bengal dyes, indicating areas of damage.
• Signs of meibomian gland dysfunction or blepharitis.

Objective Tests

• Schirmer Test – Strips of filter paper placed under the lower eyelid measure tear production over 5 minutes. <5 mm is abnormal.
• Tear Break‑Up Time (TBUT) – After fluorescein instillation, the interval between a blink and the first appearance of a dry spot is timed. <10 seconds suggests instability.
• Ocular Surface Disease Index (OSDI) questionnaire – A validated patient‑reported outcome tool that quantifies symptom severity.
• Meibography – Infrared imaging of the meibomian glands to detect dropout or atrophy.
• Osmolarity testing – Elevated tear osmolarity (>308 mOsm/L) is a hallmark of dry eye disease.

Advanced Imaging (when needed)

In refractory cases, confocal microscopy or anterior segment OCT may be used to assess corneal nerve density and epithelial thickness.

Treatment Options

Treatment is individualized based on severity, underlying cause, and patient lifestyle. The goals are to restore a stable tear film, reduce inflammation, and protect the cornea.

First‑Line (Home & Over‑the‑Counter) Measures

• Artificial tears – Preservative‑free options are preferred for frequent use; hyaluronic acid and carboxymethylcellulose formulations provide longer residence time.
• Lid hygiene – Warm compresses followed by gentle lid scrubs (e.g., diluted baby shampoo or commercially available lid wipes) improve meibomian gland function.
• Environmental modifications – Use a humidifier, avoid direct air drafts, and take regular screen‑breaks (20‑20‑20 rule).
• Omega‑3 fatty acid supplementation – 1–2 g daily of EPA/DHA has shown modest benefit in tear quality (source: NIH).
• Hydration & Blink training – Encourage adequate water intake and conscious blinking, especially during prolonged computer work.

Prescription Medications

• Anti‑inflammatory eye drops
  • Cycloplegic agents such as cyclosporine A 0.05 % (Restasis) or lifitegrast 5 % (Xiidra) reduce ocular surface inflammation and increase tear production.
  • Short courses of low‑dose corticosteroid drops (e.g., fluorometholone) may be used for acute flares under close supervision.
• Punctal plugs – Small silicone or collagen devices inserted into the tear drainage ducts to retain tears on the ocular surface.
• Taurine‑based gel or ointments – Applied at night to provide prolonged lubrication.
• Autologous serum eye drops – For severe keratitis sicca, serum derived from the patient’s blood contains growth factors that promote epithelial healing.

Procedural Interventions

• Thermal pulsation (e.g., LipiFlow) – Delivers heat and massage to unclog meibomian glands.
• Intense pulsed light (IPL) therapy – Reduces inflammation of the eyelid margin and improves gland function.
• Amniotic membrane transplantation – Reserved for severe, non‑healing corneal erosions.

When Contact Lenses Are Involved

Switch to daily‑disposable lenses, use rewetting drops compatible with lenses, or consider a brief period of lens‑free wear while the ocular surface recovers.

Prevention Tips

Even if you have never experienced dry eye, adopting the following habits can lower the risk of developing keratitis sicca:

• Maintain a balanced diet rich in omega‑3 fatty acids (flaxseed, walnuts, fatty fish).
• Stay adequately hydrated – aim for at least 8 cups of water per day.
• Take regular breaks from digital screens; blink fully during each pause.
• Wear protective eyewear in windy, dusty, or smoky environments.
• Limit exposure to smoke and environmental pollutants.
• If you wear contact lenses, follow proper hygiene and replace lenses as recommended.
• Review medication side‑effects with your physician; alternatives may exist for drugs that cause dryness.
• Schedule routine eye examinations, especially after the age of 40 or if you have an autoimmune condition.

Emergency Warning Signs

Key Take‑aways

Keratitis sicca is a common yet often under‑recognized condition that can progress from mild irritation to serious corneal damage if left untreated. Understanding the myriad causes—from age‑related tear decline to autoimmune disease—enables targeted therapy. Simple home measures, prescription eye drops, and procedural interventions together form a stepwise treatment algorithm. Most importantly, patients should be aware of red‑flag symptoms that demand urgent care to protect vision.

For more detailed guidance, consult reputable sources such as the Mayo Clinic, the CDC Vision Health, and the National Institutes of Health (NIH) review of dry eye disease.

```